-

Winning Pharma Companies Encourage a Culture of ‘Compliant Collaboration’ Between Commercial and Medical Affairs Teams

Only 39 Percent of Commercial Leaders Report a Strong to Very Strong Relationship with Medical Affairs Team, According to a New TGaS Landscape Report from Trinity Life Sciences

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, published its newest TGaS report entitled, Commercial/Medical Partnership Landscape: Driving Improvements in Communications, Coordination and Effectiveness. The report finds that pharmaceutical companies that encourage a culture of ‘compliant collaboration’ between Commercial and Medical Affairs teams ensures strong alignment that is critical to a product’s success.

“Often times within pharma, the Commercial and Medical Affairs teams are truly a tale of two cultures – each with their own specific backgrounds and agendas. Companies with strong Commercial/Medical Affairs relationships have an underlying philosophy to work with a ‘compliant collaboration’ mindset,” said Chris Welsh, Vice President, TGaS Advisors, a Division of Trinity. “This philosophy should begin at the C-suite level and permeate throughout the organization.”

While 53 percent of Medical Affairs leaders report they have an overall strong to very strong working relationship with Commercial leaders, only 39 percent of Commercial leaders report a strong to very strong relationship with Medical Affairs teams. Besides the key findings that the survey uncovers, the report also offers insights and actions pharma companies should take to strengthen the relationships between their Commercial and Medical Affairs teams.

The Landscape report is based on the responses of 20 Commercial leaders and 15 Medical Affairs leaders representing 32 separate biopharmaceutical companies. Members of the media can request a copy of the report by contacting Elizabeth Marshall at emarshall@trinitylifesciences.com.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Life Sciences’ AI Algorithm Accurately Predicts Revenue Outcomes for Over 90% of U.S. Drug Launches Far Exceeding Wall Street Analyst Attempts

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduced its artificial intelligence (AI) algorithm which accurately predicted revenue outcomes for over 90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%). Trinity’s latest white paper in its Industry Impact Series, titled Predicting Winners: AI-Powered Portfolio Management, explores the use...

Health Equity Considerations as a Differentiator in Value Narratives Provide Opportunity for Life Sciences’ Global HTA Submissions

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces a dedicated Value Center of Excellence (COE) that provides end-to-end partnership along the value journey to Market Access and Health Economics and Outcomes Research (HEOR) teams, from strategy to communication. The COE approaches U.S. and global value work through a uniquely integrated combination of market access and HEOR expertise. Trinity’s Value C...

Analysis of Disparate Health Technology Assessment Landscape Transformed With Generative AI Tools

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, today announces an enhancement to its HTA Vision offering that swiftly extracts relevant information from health technology assessments (HTAs) and Trinity expert analyses, streamlining the information-gathering process within any therapeutic area or drug class. By not only locating but also summarizing key information with generative AI (GenAI), HTA Vision trans...
Back to Newsroom